Author

Giovanni Vitulli

GlaxoSmithKline (United Kingdom)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Alex Phillipou· 1 shared Ashley P. Hancock· 1 shared Chloe L. TayleriD· 1 shared Christopher P. TinworthiD· 1 shared David F. ToughiD· 1 shared David J. HirstiD· 1 shared Despoina KoumantouiD· 1 shared Efstratios StratikosiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alex Phillipou

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Discovery of an orally available potent ER aminopeptidase 1 (ERAP1) inhibitor that enhances anti-tumor responses and limits inflammatory autoimmunity in vivo.

Christopher P. Tinworth, Justyna Wojno, Michael Adam, Stephan Gade, Ashley P. Hancock, David J. Hirst, Jonathan P. Hutchinson, Semra J. Kitchen, Despoina Koumantou, Jonathan D. Lea, Stephanie Lehmann, John Liddle, Richard Lonsdale, Margarete Neu, Leng Nickels, , Efstratios Stratikos

bioRxiv · Nov 17, 2025 · PreprintImmunology